209 related articles for article (PubMed ID: 27327137)
21. miR-20a inhibition using locked nucleic acid (LNA) technology and its effects on apoptosis of human macrophages infected by Toxoplasma gondii RH strain.
Rezaei F; Daryani A; Sharifi M; Sarvi S; Jafari N; Pagheh AS; Hashemi N; Hejazi SH
Microb Pathog; 2018 Aug; 121():269-276. PubMed ID: 29800695
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection.
Torres AG; Fabani MM; Vigorito E; Gait MJ
RNA; 2011 May; 17(5):933-43. PubMed ID: 21441346
[TBL] [Abstract][Full Text] [Related]
23. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.
Najafi Z; Sharifi M; Javadi G
J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.
Hinkel R; Penzkofer D; Zühlke S; Fischer A; Husada W; Xu QF; Baloch E; van Rooij E; Zeiher AM; Kupatt C; Dimmeler S
Circulation; 2013 Sep; 128(10):1066-75. PubMed ID: 23897866
[TBL] [Abstract][Full Text] [Related]
25. LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation.
Ali A; Grillone K; Ascrizzi S; Caridà G; Fiorillo L; Ciliberto D; Staropoli N; Tagliaferri P; Tassone P; Di Martino MT
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102221. PubMed ID: 38868363
[TBL] [Abstract][Full Text] [Related]
26. Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides.
Yamamoto T; Mukai Y; Wada F; Terada C; Kayaba Y; Oh K; Yamayoshi A; Obika S; Harada-Shiba M
Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34072682
[TBL] [Abstract][Full Text] [Related]
27. Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro.
Shimo T; Tachibana K; Saito K; Yoshida T; Tomita E; Waki R; Yamamoto T; Doi T; Inoue T; Kawakami J; Obika S
Nucleic Acids Res; 2014 Jul; 42(12):8174-87. PubMed ID: 24935206
[TBL] [Abstract][Full Text] [Related]
28. Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
Naseri Z; Oskuee RK; Forouzandeh-Moghadam M; Jaafari MR
Stem Cell Rev Rep; 2020 Jun; 16(3):541-556. PubMed ID: 31898802
[TBL] [Abstract][Full Text] [Related]
29. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia.
Sharifi M; Salehi R
Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates.
Mol Ther Nucleic Acids; 2016 Jul; 5(7):e336. PubMed ID: 27434681
[No Abstract] [Full Text] [Related]
31. A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo.
Gupta N; Fisker N; Asselin MC; Lindholm M; Rosenbohm C; Ørum H; Elmén J; Seidah NG; Straarup EM
PLoS One; 2010 May; 5(5):e10682. PubMed ID: 20498851
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Cell Type-Specific Effects of MicroRNA-92a Provides Novel Insights Into Target Regulation and Mechanism of Action.
Rogg EM; Abplanalp WT; Bischof C; John D; Schulz MH; Krishnan J; Fischer A; Poluzzi C; Schaefer L; Bonauer A; Zeiher AM; Dimmeler S
Circulation; 2018 Nov; 138(22):2545-2558. PubMed ID: 30571345
[TBL] [Abstract][Full Text] [Related]
33. A sensitive alternative for microRNA in situ hybridizations using probes of 2'-O-methyl RNA + LNA.
Søe MJ; Møller T; Dufva M; Holmstrøm K
J Histochem Cytochem; 2011 Jul; 59(7):661-72. PubMed ID: 21525189
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies.
Javanmard SH; Vaseghi G; Ghasemi A; Rafiee L; Ferns GA; Esfahani HN; Nedaeinia R
Cancer Cell Int; 2020; 20():384. PubMed ID: 32788885
[TBL] [Abstract][Full Text] [Related]
35. miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.
Santolla MF; Lappano R; Cirillo F; Rigiracciolo DC; Sebastiani A; Abonante S; Tassone P; Tagliaferri P; Di Martino MT; Maggiolini M; Vivacqua A
J Exp Clin Cancer Res; 2018 May; 37(1):94. PubMed ID: 29716623
[TBL] [Abstract][Full Text] [Related]
36. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
[TBL] [Abstract][Full Text] [Related]
37. An LNA-based loss-of-function assay for micro-RNAs.
Naguibneva I; Ameyar-Zazoua M; Nonne N; Polesskaya A; Ait-Si-Ali S; Groisman R; Souidi M; Pritchard LL; Harel-Bellan A
Biomed Pharmacother; 2006 Nov; 60(9):633-8. PubMed ID: 16962735
[TBL] [Abstract][Full Text] [Related]
38. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
[TBL] [Abstract][Full Text] [Related]
39. miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis.
Qi H; Fu J; Luan J; Jiao C; Cui X; Cao X; Zhang Y; Wang Y; Kopp JB; Pi J; Zhou H
Biochem Biophys Res Commun; 2020 Feb; 522(3):618-625. PubMed ID: 31787235
[TBL] [Abstract][Full Text] [Related]
40. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes.
Válóczi A; Hornyik C; Varga N; Burgyán J; Kauppinen S; Havelda Z
Nucleic Acids Res; 2004 Dec; 32(22):e175. PubMed ID: 15598818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
